Difference between revisions of "Scientific Articles on Psychedelics"
From DMT-Nexus Wiki
TheTraveler (Talk | contribs) (→Other) |
TheTraveler (Talk | contribs) m |
||
Line 104: | Line 104: | ||
| | | | ||
}} | }} | ||
+ | |||
==DMT== | ==DMT== | ||
Line 135: | Line 136: | ||
| | | | ||
}} | }} | ||
+ | |||
==Ibogaine== | ==Ibogaine== | ||
Line 166: | Line 168: | ||
| | | | ||
}} | }} | ||
+ | |||
==LSD== | ==LSD== | ||
Line 179: | Line 182: | ||
| | | | ||
}} | }} | ||
+ | |||
==Peyote== | ==Peyote== | ||
Line 198: | Line 202: | ||
| | | | ||
}} | }} | ||
+ | |||
==Psilocybin== | ==Psilocybin== | ||
Line 247: | Line 252: | ||
| | | | ||
}} | }} | ||
+ | |||
==Salvia Divinorum== | ==Salvia Divinorum== | ||
Line 260: | Line 266: | ||
| | | | ||
}} | }} | ||
+ | |||
==Other== | ==Other== |
Revision as of 22:42, 16 February 2009
Note: | This page is a work in progress -- its content throughout is not yet complete. |
Ayahuasca
Ayahuasca and SSRI Interactions | Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369. |
Ayahuasca Adolescents ritual use | Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144. |
ayahuasca first time psychological after effects | Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30. |
Ayahuasca and human destiny | McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234. |
Another Ayahuasca EEG study | Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628. |
Ayahuasca in adolescence psychiatric evaluation |
ayahuasca in cross cultural perspective |
Ayahuasca neuroimaging |
Bringing Ayahuasca to clinical laboratory |
Effects of ayahuasca on panic and anxiety.pdf |
Globalization of ayahuasca |
Human pharmacology of ayahuasca |
Pharmacokinetics of hoasca in healthy humans |
Risk assessment of ritual ayahuasca use |
Thesis - Ayahuascapharmacology part1 |
Thesis - ayahuascapharmacology part2 |
Various alkaloid profiles in aya decoction |
DMT
DMT and BCarbolines in human plasma after dose |
DMT endogenous anxiolytic role |
DMT in psychiatric patients |
DMT psychopharmacology |
Excretion of DMT in Psychiatric Patients |
Ibogaine
Fatalities after ibogaine use |
Ibogaine and cocaine abuse |
Ibogaine and facilitation of memory retrieval |
Ibogaine mechanisms of anti addiction |
Ibogaine safety and efficacy |
LSD
Long term effects of LSD |
Therapy with LSD |
Peyote
A Study on mescaline in human subjects |
Peyote long term psychological cognitive effects |
Prehistoric peyote use |
Psilocybin
Cluster headache lsd psilocybin |
Effects of psilocybin on humans |
Effects of psilocybin on perception of time |
Psilocybin and mystical experiences |
Psilocybin and OCD |
Psilocybin investigator brochure |
Psilocybin, attention and working memory |
Psychedelic mushrooms in buddhist tradition |
Salvia Divinorum
Salvia divinorum pattern of use |
Salv_A_PNAS |
Other
Bufo alvarius - a potent hallucinogen |
Entheogens and education potential |
Hallucinogens and redemption |
HPPD - flashbacks |
JPharmBioAn-41-3-872 |
Mining_Recepterome_Review_JBC |
Natural hallucinogens growing in USA |
Nichols - Hallucinogens |
Pharmañopo - Yopo pharmacology |
Pharmepena - epena pharmacology |
Proposed Mechanism for Dreams and Sleep |
Psychedelic adverse effects |
Psychointegrators multidisciplinary approach |
Psychopharmacology of hallucinogens |
Psychosis and hallucinogens consciousness model |
Reducing drug problems with set and setting |
Serotonin and hallucinogens |
Study of Values of psychedelic users |